SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer.
Virginia SunKatherine A GuthrieTracy E CraneKathryn B ArnoldSarah ColbySarah G FreylersytheChrista M Braun-InglisRoxanne TopacioCraig A MessickJoseph C CarmichaelAndrew A MuskovitzMohammed NashawatyMadhuri BajajStacey A CohenDevin C FlahertyMark A O'RourkeLee JonesRobert S KrouseCynthia A ThomsonPublished in: Cancer (2024)
SWOG S1820 did not provide evidence of benefit from the AIMS-RC intervention relative to the attention control. Select secondary end points did demonstrate improvements. The study was highly feasible and acceptable for participants in the National Cancer Institute Community Oncology Research Program. Findings provide strong support for further refinement and effectiveness testing of the AIMS-RC intervention.